Insmed appoints Myrtle Potter to its board
This article was originally published in Scrip
Insmed has appointed Myrtle Potter to its board of directors. Ms Potter is currently CEO of Myrtle Potter & Company, a life sciences and healthcare advisory firm she founded in 2005. She was previously the president of commercial operations and chief operating officer of Genentech. Ms Potter serves as a director of Liberty Mutual, Rite Aid, Everyday Health and Proteus Digital Health, and as a Trustee of the University of Chicago. She served on the board of Medco Health Solutions from December 2007 until its acquisition by Express Scripts in April 2012, and continued as a director of Express Scripts until June 2012.